Detalhe da pesquisa
1.
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial.
Lancet
; 401(10371): 105-117, 2023 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495879
2.
A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer.
Invest New Drugs
; 36(2): 288-298, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29277856
3.
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 17(6): 811-821, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27155741
4.
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.
PLoS Med
; 13(12): e1002136, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27923043
5.
Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial.
Br J Cancer
; 114(5): 505-9, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26867157
6.
A Randomized Controlled Trial of a Nurse-Led Supportive Care Package (SurvivorCare) for Survivors of Colorectal Cancer.
Oncologist
; 21(8): 1014-23, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27306909
7.
Prognostic factors of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.
Oncologist
; 20(2): 143-50, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25582141
8.
Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer.
Breast Cancer Res
; 16(2): R44, 2014 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24762066
9.
Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells.
Clin Cancer Res
; 30(2): 304-314, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976042
10.
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer.
Thorax
; 68(12): 1095-104, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23878161
11.
Cancer stem cells in lung cancer: Evidence and controversies.
Respirology
; 18(5): 757-64, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23586700
12.
MYC drives platinum resistant SCLC that is overcome by the dual PI3K-HDAC inhibitor fimepinostat.
J Exp Clin Cancer Res
; 42(1): 100, 2023 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098540
13.
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study.
Eur Urol
; 84(3): 321-330, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37277275
14.
Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.
Oncogene
; 41(1): 138-145, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34675406
15.
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial.
J Immunother Cancer
; 10(4)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35414591
16.
Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer.
Clin Epigenetics
; 13(1): 226, 2021 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922619
17.
The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET.
Breast Cancer Res
; 12(3): R37, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20565953
18.
Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.
NPJ Precis Oncol
; 3: 21, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31482136
19.
Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer.
Oncogene
; 38(10): 1661-1675, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30348992
20.
Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer.
Clin Cancer Res
; 24(10): 2276-2284, 2018 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29506988